http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0216743-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
filingDate 1986-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1987-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0216743-A3
titleOfInvention Galenical forms of verapamil, preparation thereof and medicaments containing them
abstract The invention relates to a novel galenic form of verapamil which show an excellent bioavailability. The novel galenic form comprises microgranules containing a verapamil addition salt with an acid, associated to at least one wetting agent. The microgranules are coated with a porous membrane constituted of a synthetic polymer associated to an adjuvant.
priorityDate 1985-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8300009-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2056278-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0153104-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0063266-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0080341-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0142877-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520

Total number of triples: 24.